In 2025, nearly $100 million worth of medicines were sold through the Liki24 marketplace. This is 20.5% more than the previous year. The reason for this is the expansion that the company has been carrying out in Europe since 2020. Currently, it has launched online services in 10 countries, and through the Liki24 global platform, it is available in over 40 more countries. Business in the EU generates 70% of the company's revenue.

However, the "first touch" to European market was unsuccessful. Liki24 entered the Polish market in 2020, but closed the project two years later, losing $0.5 million. At the end of 2025, the company returned to the market. Poland.

In an interview, Anton Avrinsky, CEO and co-founder of liki24, shared in great detail what lessons he learned from his first failure, what work he did to correct his mistakes, and what he advises Ukrainian entrepreneurs who want to scale up in Europe. LIGA.net

Subscribe to LIGA PRO to read this article. Go to the full version of the page.